Finding the best prices at pharmacies near you...


Liver Cancer

Liver Cancer

Liver cancer is cancer that starts in the cells of the liver, occurring when liver cells mutate and form tumors. There are a number of types of cancer that may form in the liver, for example, intrahepatic cholangiocarcinoma, hepatoblastoma, and hepatocellular carcinoma, which is the most common. 

Risk factors for liver cancer include cirrhosis; chronic infections such as hepatitis B or hepatitis C; hereditary liver diseases; diabetes; and excessive alcohol consumption. Preventative measures to minimize the chance of liver cancer developing include maintaining a healthy weight, not drinking alcohol, or only drinking in moderation, and vaccination against hepatitis B. 

Symptoms of liver cancer include a loss of appetite, unexplained weight loss, upper abdominal pain, nausea, vomiting, fatigue, weakness, jaundice, anemia, and white stools.

Treatment of liver cancer may involve surgery to remove the tumor, liver transplant, chemotherapy, radiation therapy, and targeted drug therapy. Protein kinase inhibitors are often prescribed to treat liver cancer. 


Drugs Used To Treat Liver Cancer:

Protein Kinase Inhibitors
Commonly used to treat Liver Cancer, Renal Cancer.

Drugs Related to Liver Cancer:

Protein Kinase Inhibitors
Commonly used to treat Liver Cancer, Renal Cancer.

Blog Posts Related to Liver Cancer:

First biosimilar to cancer drug Neulasta approved by FDA

Fulphila (pegfilgrastim-jmdb) is the first biosimilar to Neulasta (pegfilgrastim) to gain approval from the US Food and Drug Administration (FDA). The Mylan GmbH medicine was approved as a treatment to reduce the risk of infection as suggested by febrile neutropenia (fever caused by a lack of...

Read More

CDC: Obesity ‘increases risk of 13 types of cancer’

Overweight or obese Americans are at a higher risk of developing cancer, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC). At least 13 different types of cancer are associated with obesity, yet figures suggest more than half of Americans are...

Read More

FDA approves Stivarga for liver cancer treatment

The US Food & Drug Administration (FDA) has approved the drug Stivarga (regorafinib) for treatment of hepatocellular carcinoma (HCC) or liver cancer. It is the first FDA-approved treatment for this condition in nearly a decade. Developed by Bayer HealthCare Pharmaceuticals, Stivarga is already...

Read More